1.4 Colon cancer pathogenesis - gene mutations
Increasing numbers of mutant genes accumulate in cells as they evolve from a more benign to a more malignant growth state.
We know so much about the genetic basis of tumor progression in the colon because the colonic epithelium is relatively accessible through colonoscopy
They examined the genomes of sizable groups of
small colonic adenomas, mid-sized adenomas, large adenomas, and carcinomas
It was plausible that as colonic tissues advanced progressively from normalcy to a high-grade malignancy
The epithelial cells in these various tissues would accumulate increasing numbers of mutations in various genes.
(NOTE: the identities of the tumor suppressor genes that participate in colon cancer pathogenesis were not known when they began their work, so they searched instead for chromosomal regions that suffered loss of heterozygosity (LOH) during tumor progression)
Landmark research: Colon Cancer
Early-stage adenomas often showed
loss of heterozygosity in the long arm of Chromosome 5
Almost half of slightly larger adenomas showed
in addition, a mutant K- ras oncogene.
Even larger adenomas tended to showed
high rates of LOH on the long arm of Chromosome 18
LOH on the short arm of Chromosome 17
These observations support the idea that
epithehial cells acquire increasingly neoplastic phenotypes during the course of tumor progression
Increasingly neoplastic phenotypes during the course of tumor progression
Tumor progression
Involves the activation of one proto-oncogene into an oncogene and the inactivation of at least three tumor suppressor genes
This was the first suggestion of a phenomenon that is now recognized to be quite common in human tumor cell genomes.
The most obvious way to rationalize the steps in colon cancer development involves
an ordered succession of genetic changes that strike the genomes of colonic epithelial cells as they evolve progressively toward malignancy
Colon cancer pathogenesis.
Most colon cancers will begin with a Chromosome 5 alteration, but then will take alternative genetic paths on the road toward full-fledged malignancy
The loss of heterozygosity on Chromosome 5q is almost always the first in the progression
the precise order of the subsequent changes may vary from tumor to tumor.
Some of these mutations appear to confer growth advantages at an early stage of tumor development
Other mutations promote the later stages, including invasion and metastasis, which are required for the malignant phenotype
Видео 1.4 Colon cancer pathogenesis - gene mutations канала Mark Temple
We know so much about the genetic basis of tumor progression in the colon because the colonic epithelium is relatively accessible through colonoscopy
They examined the genomes of sizable groups of
small colonic adenomas, mid-sized adenomas, large adenomas, and carcinomas
It was plausible that as colonic tissues advanced progressively from normalcy to a high-grade malignancy
The epithelial cells in these various tissues would accumulate increasing numbers of mutations in various genes.
(NOTE: the identities of the tumor suppressor genes that participate in colon cancer pathogenesis were not known when they began their work, so they searched instead for chromosomal regions that suffered loss of heterozygosity (LOH) during tumor progression)
Landmark research: Colon Cancer
Early-stage adenomas often showed
loss of heterozygosity in the long arm of Chromosome 5
Almost half of slightly larger adenomas showed
in addition, a mutant K- ras oncogene.
Even larger adenomas tended to showed
high rates of LOH on the long arm of Chromosome 18
LOH on the short arm of Chromosome 17
These observations support the idea that
epithehial cells acquire increasingly neoplastic phenotypes during the course of tumor progression
Increasingly neoplastic phenotypes during the course of tumor progression
Tumor progression
Involves the activation of one proto-oncogene into an oncogene and the inactivation of at least three tumor suppressor genes
This was the first suggestion of a phenomenon that is now recognized to be quite common in human tumor cell genomes.
The most obvious way to rationalize the steps in colon cancer development involves
an ordered succession of genetic changes that strike the genomes of colonic epithelial cells as they evolve progressively toward malignancy
Colon cancer pathogenesis.
Most colon cancers will begin with a Chromosome 5 alteration, but then will take alternative genetic paths on the road toward full-fledged malignancy
The loss of heterozygosity on Chromosome 5q is almost always the first in the progression
the precise order of the subsequent changes may vary from tumor to tumor.
Some of these mutations appear to confer growth advantages at an early stage of tumor development
Other mutations promote the later stages, including invasion and metastasis, which are required for the malignant phenotype
Видео 1.4 Colon cancer pathogenesis - gene mutations канала Mark Temple
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Oncogenetics - Mechanism of Cancer (tumor suppressor genes and oncogenes)Colon Cancer Carcinogensis4.3 How is ras involved in signalingColorectal Cancer - OverviewPrecision Medicine in Oncology: Monitoring Cancer Using a Urine Sample | Antonius Schuch | TEDxUCSDColon Cancer: Pathology, Symptoms, Screening, Cause and Risk Factors, AnimationGenetic Recombination and Gene MappingBRCA mutationTargeting Cancer Pathways: The Epigenetics QuestionPart 1: How Does New Genetic Information Evolve? Point MutationsUnderstanding the mutations behind colorectal cancer | Dr Kate MarksNEOPLASIA 5: DEFECTS IN DNA REPAIR, DNA repair genes & Associated CancersCancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey WeberColorectal carcinoma - causes, symptoms, diagnosis, treatment, pathologyGenetics TermsColorectal Cancer: The ins and outs | John Carethers | TEDxUofMCancer biology part 5 Genes associated with cancerMSI in CRC – Microsatellite instability in colorectal cancer–Please participate in our survey below!Lynch Syndrome - HNPCC – Hereditary Non-Polyposis Colorectal CancerMolecular Assays for Colorectal Cancer Care - William Grady, MD